ALTHEA TECHNOLOGIES ANNOUNCED THE DEVELOPMENT OF A MOLECULAR DIAGNOSTIC CAPABLE OF CLEARLY DIFFERENTIATING VARIOUS TYPES OF CHILDHOOD CANCERS